You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 3376 to 3400 of about 5877
Next 25
12/11/2008
21st Century Brain Surgery: Minimally Invasive Endonasal Approach, Experienced Surgeons Give Patients the Advantages They Need
12/10/2008
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.
12/08/2008
Non-Malignant Patient and Caregiver Support Group followed by Special Guest Speaker Dr. Patrick J. Kelly
12/07/2008
Updated survivor story for Scott
12/05/2008
Drug slows brain cancer, Calgary researchers say
12/04/2008
Ranbaxy in pact to market BioPro`s brain tumour drug (Gliadel) in India news
11/26/2008
The National Brain Tumor Society is hosting our 12th annual teleconference on December 2, 2008
Final Data From Phase 1 Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at the Society for Neuro-Oncology’s Annual Meeting
RTOG Reports That Chemotherapy Added to Radiotherapy Improves Survival (For low grade gliomas)
11/25/2008
Brain-cancer center at Swedish maps tumors to design treatment
STUDIES SHOW NOVEL DEVICE MAY ENHANCE CHEMOTHERAPY TREATMENT IN BRAIN TUMORS
Free Teleconference on Latest Glioma Treatments: A Program for Patients and Families Presented by: Dr. Howard Fine
11/23/2008
A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma.
11/21/2008
Florida Brain Tumor Association annual brain tumor conference.
11/19/2008
Phase I/II Trial Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177.
Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme.
Pediatric glioblastomas: A histopathological and molecular genetic study.
Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience.
Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab (Avastin) plus irinotecan (CPT-11).
abCorp developing new brain cancer test
11/17/2008
A better way to find brain tumors
The relative risk of brain cancer
Celprogen Introduces an in vivo Model for Human Brain Cancer (Human Glioblastoma GBM) for Drug Discovery Applications
11/15/2008
Added article about proton beam radiation
11/14/2008
New brain tumor support group - North Shore University Hospital, Long Island, NY